Guardant Health, Inc. (GH)
Blood tests that detect cancer mutations and guide treatment decisions.
$145.43-0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+251.1%
The outlook
Guardant Health is trading near $145.43 with strong analyst backing—the consensus sits at "Strong Buy" across 24 analysts. The stock sits well above both its 50- and 200-day moving averages and trades roughly 79% of the way through its 52-week range. The average analyst price target lies about 18% above the current price.
What’s behind the score
Analyst consensusStrong Buy — 1.3 avg of 24 analysts
Price trendAbove its 50- & 200-day averages
52-week range79% of the way from its 52-week low to high
Price targetAvg target +18% vs current price
Analyst price target
~12-month · 24 analysts$171.08average target+17.6% vs now
Now $145.43
Low $90.00High $215.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$19.28B
52-wk high
$174.08
52-wk low
$40.35
50-day avg
$137.81
200-day avg
$105.58
Trailing P/E
—